Status:
COMPLETED
Diastolic Dysfunction and Interstitial Lung Edema in Septic Patients
Lead Sponsor:
Universitätsklinikum Hamburg-Eppendorf
Conditions:
Sepsis
Diastolic Dysfunction
Eligibility:
All Genders
18+ years
Brief Summary
Sepsis is one of the most challenging conditions with an exceptionally high mortality rate. Diastolic Dysfunction is common in septic patients and has been found to be associated with mortality. Howev...
Eligibility Criteria
Inclusion
- Patients on the intensive care unit diagnosed with SIRS (systemic inflammatory response syndrome) or Sepsis.
Exclusion
- Patients with hemodynamically relevant cardiac defects.
- Patients with mitral valve replacement.
- Patients with pericardial effusion.
- Patients with atrial fibrillation.
- Patients with pacemaker therapy.
- Patients with BMI \> 35 kg/m2.
- Patients with poor examination conditions for ultrasound.
Key Trial Info
Start Date :
October 11 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 3 2019
Estimated Enrollment :
83 Patients enrolled
Trial Details
Trial ID
NCT03768752
Start Date
October 11 2018
End Date
May 3 2019
Last Update
May 14 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universitätskrankenhaus Hamburg-Eppendorf
Hamburg, Germany, 20246